Infectious Disease Control
Lianhua Qingwen -- The Leading TCM In Global Anti-Pandemic Programs
SHIJIAZHUANG, China, March 11, 2021 /PRNewswire/ -- As an epitome of the Chinese civilization, traditional Chinese medicine or TCM, and western medicine, reinforce each other to protect and improve people's health. Since the outbreak of the COVID-19 pandemic,China has been strengthening the inte...
2021-03-11 13:46
3551
First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic
BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-...
2021-03-11 08:00
1440
First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic
BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Ni...
2021-03-11 08:00
1400
HKBN Enterprise Solutions Offers Prompt Support to Catering Businesses with PHILIPS UV-C Air Disinfection Device
HONG KONG, March 9, 2021 /PRNewswire/ -- Understanding the special operational needs of catering businesses during COVID, HKBN Enterprise Solutions ("HKBNES") has teamed up with Signify (formerly Philips Lighting) to bring to the market – in particular restaurants and catering premises –PHILIPS U...
2021-03-09 16:29
3210
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...
2021-03-05 04:01
5247
Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service
IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...
2021-03-04 14:33
3690
e-condLIFE: Cost of human life and business shut down can be minimized with this new prevention technology
* A smarter preventative way to keep family members safe * Peace of mind for staff and customers that the premises are being disinfected 24 hours KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Since launching inJune 2020, e-condLIFE has been well received and proven to be effective. Dr...
2021-03-03 09:00
3074
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants
BVX-0320 and Covid-T to have capability to address UK, Brazilian and South African Virus Variants VANCOUVER, B.C., March 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer app...
2021-03-01 21:00
5959
VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections
- VLP BioTech Has Developed a Vaccine-Based Viral-Entry-Inhibitor for the Treatment of Chronic HBV/HDV. - The Vaccine-Based Treatment Has Significant Advantages Compared to a Peptide-Based, Entry-Inhibitor (Hepcludex). SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- VLP BioTech, Inc., a private, pre...
2021-02-24 22:00
3580
Skybox Security Announces 2020 Partner Awards
Channel and distributor partners recognized for commitment to customer excellence and performance SAN JOSE, Calif., Feb. 23, 2021 /PRNewswire/ -- Skybox Security, a global leader in security posture management, today announced the winners of its 2020 Partner Awards. The inaugural award program r...
2021-02-23 22:05
2697
INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa
Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflects INOVIO's focus on and continued commitment to the fight against infectious diseases Trial fully f...
2021-02-23 21:00
5617
BioVaxys Announces Appointment To Its Scientific Advisory Board
VANCOUVER, B.C., Feb. 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Kartik Chandran Ph.D....
2021-02-22 21:00
2723
Taming the Black Swan: Multilateral diplomacy for sustainable growth in the era of disruption
BANGKOK, Feb. 22, 2021 /PRNewswire/ -- Mr. Don Pramudwinai, Deputy Prime Minister and Minister of Foreign Affairs of the Kingdom of Thailand, and a career diplomat, discussed his vision of the role of diplomacy in Post-Covid 19 sustainability in this opinion piece first published on19 Feb 2021 in...
2021-02-22 14:20
3240
Seegene's saliva test for COVID-19 is just as effective as NPS test
SEOUL, South Korea, Feb.18, 2021 /PRNewswire/ -- A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine,...
2021-02-18 11:43
2386
Vax-Immune Diagnostics Takes Innovative Women's Health Diagnostic Device to European Markets to Improve Maternal Group B Strep Testing Processes
HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Vax-Immune Diagnostics announces today it has received CE Mark approval for its first-in-class medical device, LabReady® GBS.LabReady's Group B Strep product is the first in Vax-Immune Diagnostics' lineup of women's health solutions that helps avoid life-th...
2021-02-18 01:03
1793
EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)
PROVIDENCE, R.I., Feb. 18, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU,India, and United States (funded by the EU and India) with the aim of develop...
2021-02-18 01:01
2583
RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107
- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...
2021-02-17 20:00
4303
Indian conglomerate, Godrej & Boyce aims to strengthen Vaccine Cold Chain across the world
Cold Chain Partner to the world's largest covid vaccination drive in India, refrigeration expert Godrej & Boyce launches 'made inIndia' ultra-low-temperature freezers (below -80°C) Offers vaccine cold chain solutions across all temperature bands MUMBAI, India, Feb. 17, 2021 /PRNewswire/ -- Godr...
2021-02-17 11:00
4876
88% Vaccination Rate Across Yas Island Employees
Abu Dhabi's leading leisure and entertainment destination to be among the first in the world to vaccinate most of itsemployees, signaling its commitment to health and safety ABU DHABI, UAE, Feb. 17, 2021 /PRNewswire/ -- Eighty-eight per cent employees working at attractions, experiences, hotels,...
2021-02-17 09:00
919
Quark Expeditions Adopts Breakthrough Rapid PCR Testing as Part of its S.A.F.E. COVID Policy
SEATTLE, Feb. 16, 2021 /PRNewswire/ -- Quark Expeditions, the recognized leader in Polar Adventures, has secured rapid onsite testing capability as part of its industry-leading S.A.F.E. COVID Policy, designed to protect travelers' health—and financial investment—when expedition travel resumes. ...
2021-02-17 03:19
1861
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4434
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3617
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3590
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
2025-12-05 21:45
3387